Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.

Answers from the Lab

Feb 06, 2024•18 min•Ep. 277

--:--

Listen in podcast apps:

Apple Podcasts

Spotify

Download

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler test ordering.

(00:32)
Could you provide us with a little bit about yourself and your background?

(02:56)
Would you elaborate on the role of you and the Mayo Clinic team in advancing insights with the use of mass spectrometry and its initial launch?

(05:38)
Please share about Quantitative MASS-FIX and its specificity, and which patients should have this testing and when it should be performed.

(09:42)
Is this a more simplified ordering menu?

(15:01)
Would you elaborate on how this assay supports the IMWG guidelines?

(16:01)
Are there any closing remarks you would like to add?

For the best experience, listen in Metacast app for iOS or Android